Clinical Trial Update: Buspirone Treatment of Iatrogenic Dyskinesias in Advanced Parkinson' Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating buspirone for treatment of iatrogenic dyskinesias in advanced Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Buspirone (buspirone)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Parkinson | Phase 3 | Status: COMPLETED